| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8629765 | Diabetes Research and Clinical Practice | 2018 | 32 Pages |
Abstract
This review indicates that GLP-1 has no short-term effect on REE but may decrease DIT. The GLP-1RA exenatide and liraglutide have a neutral effect on REE, although it is not possible to rule out an increase in REE following prolonged treatment.
Keywords
SMTPICOSiNKTTEENGTRCTPAEEPYYGLP-1RARMRT2DGLP-1ChFIHDFFMETDEPHPPAIEEPWSREEinvariant natural killer T cellsglucagon-like peptide-1 receptor agonistResting metabolic rateResting energy expenditurestandard deviationDITTemChoischemic heart diseasenormal glucose toleranceGastric emptyingDiet-Induced Thermogenesisfat-free massBody massstandard errorstandard error of meanIntravenousType 2 diabetessubcutaneousPrader-Willi syndromeSomatostatinconfidence intervalSEMSystematic reviewEffective Public Health Practice ProjectChronic heart failureEnergy expenditureGrowth hormonebody weightglucagon-like peptide-1peptide YYRandomized Clinical TrialCarbohydrateTotal Energy Expenditurenot reportedGLP-1 receptor agonists
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Michel Garcia Maciel, Bruna Teles Soares Beserra, Fernanda Cerqueira Barroso Oliveira, Carolina Martins Ribeiro, Michella Soares Coelho, Francisco de Assis Rocha Neves, Angélica Amorim Amato,